Yunpeng Liu - Concepedia

Author

Yunpeng Liu

China Medical University ORCID

Also Known As

Liu Yun-Peng, Liu Yunpeng, Liu, Yunpeng, Y Liu, Y P Liu, Y. Liu, Y.‐Q. Liu, YUNPENG LIU, Yahui Liu, Yan Tan

327

Publications

Citations

H-Index

177

Concepts

All Affiliations

China Medical University First Hospital of China Medical University Peking University Chinese Academy of Medical Sciences & Peking Union Medical College Jinzhou Medical University

About

Yunpeng Liu is an author at China Medical University specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	73	4K
2	Engineering	6	6	327
3	Natural Sciences	6	6	219
4	Health Sciences	3	3	64
5	Public Health	1	1	80

Yunpeng Liu

163

Publications

Citations

H-Index

Page 1

	Year	Citations
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress Peter M. Bruno, Yunpeng Liu, Ga Young Park, Nature Medicine Reductive StressApoptosisRibosome Biogenesis StressCell DeathRadiation Oncology	2017	510
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, The Lancet Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma	2023	415
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02) Feng‐Hua Wang, Xiaoli Wei, Jifeng Feng, Journal of Clinical Oncology	2021	336
Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial Shun Lü, Jie Wang, Yan Yu, Journal of Thoracic Oncology	2021	264
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Shukui Qin, Li Qiu, Shanzhi Gu, The Lancet. Gastroenterology & hepatology HepatologyMedicinePathologyLiver CancerCancer Treatment	2021	243
Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma H Cai, X Liu, Jian Zheng, Oncogene Enhances Tumor-induced AngiogenesisAngiogenesisGliomaMedicineNon-coding Rna Taurine	2016	208
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis Yibo Fan, Xiaofang Che, Jinglei Qu, Annals of Surgical Oncology Gastrointestinal OncologyMedicineImmunologyGastroenterologyPathology	2019	179
Artificial intelligence detection of distal radius fractures: a comparison between the convolutional neural network and professional assessments Kaifeng Gan, Dingli Xu, Yimu Lin, Acta Orthopaedica	2019	173
PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells Dan Li, Xiujuan Qu, Kezuo Hou, Anti-Cancer Drugs Gastric Cancer CellsCell RegulationHuman LeukemiaBufalin Induces ApoptosisChemoprevention Strategy	2008	157
Reduced Expression of METTL3 Promotes Metastasis of Triple-Negative Breast Cancer by m6A Methylation-Mediated COL3A1 Up-Regulation Yu Shi, Chunlei Zheng, Yue Jin, Frontiers in Oncology	2020	146

Page 1